Clinical Trials in Arizona

Showing 10601-10620 of 16,770 trials

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00436618

RATIONALE: Everolimus may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the cancer. PURPOSE: This phase II trial is studying the side effects and how well everolimus works in treating patients with lymphoma that has relapsed or not responded to previous treatment.

LeukemiaLymphomaLymphoproliferative Disorder

Mayo Clinic277 participantsStarted Aug 2005

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States

COMPLETEDPhase 1/231 miles

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

NCT00049127

This phase I/II trial is studying the side effects and best dose of imatinib mesylate and to see how well it works in treating patients with a recurrent brain tumor that has not responded to previous surgery and radiation therapy. Imatinib mesylate may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth.

Adult Anaplastic OligodendrogliomaAdult Mixed GliomaAdult Oligodendroglioma+1 more

Alliance for Clinical Trials in Oncology64 participantsStarted Jun 2003

Scottsdale, Arizona, United States • Hartford, Connecticut, United States • Jacksonville, Florida, United States +226 more locations

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

Find Trials by Condition in Arizona

Surgery With or Without Internal Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris

A Study to Evaluate the Effect of AG-881 on the Pharmacokinetics of a Single Dose of Lamotrigine in Healthy Adults

Stand & Move at Work

Safety and Efficacy of ENV515 Travoprost Extended Release (XR) in Patients With Bilateral Ocular Hypertension or Primary Open Angle Glaucoma

Efficacy and Safety of Semaglutide Versus Dulaglutide as add-on to Metformin in Subjects With Type 2 Diabetes.

Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC)

Metabolic Tracking and Weight Gain During Pregnancy

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)

A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's Disease

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

Trial of IMO-8400 in Adult Patients With Dermatomyositis

Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

Akt Inhibitor MK2206 or Everolimus in Treating Patients With Refractory Kidney Cancer

A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study)

ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies